Research
Findings show that patients who received a blood or marrow transplant as a child may be at a higher risk of related death.
UAB is renewed for another five years in NeuroNEXT, a national clinical research program in brain disorders.
UAB was part of a groundbreaking trial that is believed to be the first time it has been proved that the risk of mild cognitive impairment and dementia can be reduced through high blood-pressure treatment.
Researchers found that prolonged oxygen supplementation adversely affected the development of memory function in preterm infants.
Two new studies will have an intriguing mix of catalysts, “tunable” chemical bonds, supercomputers and ultrafast lasers.
UAB in Antarctica has fruitful research season on Earth’s southernmost continent.
A gene mutation causes wrinkled skin and hair loss; turning off that mutation restores the mouse to normal appearance.
The mechanism the tuberculosis pathogen uses in its escape suggests possible therapies to improve patient outcomes.
A gene called TXNIP was the answer, and it led to a drug called verapamil and a successful diabetes trial.
Significant novel findings published by UAB researchers established verapamil as a successful therapeutic approach to target loss of beta cell function caused by Type 1 diabetes.
Page 6 of 104